Qualified Person for Pharmacovigilance(QPPV)
The designated EU-based individual responsible for the establishment and maintenance of a Marketing Authorization Holder's pharmacovigilance system.
Usage Examples
- The QPPV was named in the Pharmacovigilance System Master File and is available 24/7 for authority contact.
- Small biotech outsourced QPPV services to a specialized pharmacovigilance provider covering EU requirements.
What is QPPV?
The Qualified Person for Pharmacovigilance (QPPV) is a named individual residing and operating in the EU/EEA with personal legal responsibility for the EU pharmacovigilance system of a Marketing Authorization Holder. EU Directive 2001/83/EC (as amended) requires each MAH to appoint a QPPV; the role is formalized in the Pharmacovigilance System Master File (PSMF).
QPPV responsibilities include: establishment and maintenance of the pharmacovigilance system, oversight of the MAH's safety profile for EU products, periodic safety update reports, signal detection outputs, risk management plans, and serving as the single point of contact for EMA and national competent authorities on pharmacovigilance matters. The QPPV must have 24/7 availability and can be held personally accountable for system failures. Many small and mid-sized companies outsource QPPV services to specialized providers.
Regulatory Context
This term appears most often in pharmacovigilance workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside DIRECTIVE 2001 83 EC, REGULATION EC 726 2004, GVP MODULE I.
When This Matters
- The QPPV was named in the Pharmacovigilance System Master File and is available 24/7 for authority contact.
- Small biotech outsourced QPPV services to a specialized pharmacovigilance provider covering EU requirements.
Common Mistakes
- Treating safety signal reviews as periodic instead of continuous.
- Not linking new enforcement letters to internal CAPA and labeling workflows.
- Using static templates for dynamic benefit-risk communication updates.
Related Regulations
Frequently Asked Questions
No, but the MAH retains ultimate responsibility. Many small and mid-sized MAHs contract QPPV services from specialized providers. The PSMF documents the arrangement. FDA-style PV responsibility is separate from QPPV; global companies often have distinct roles.
EU GVP Module I requires appropriate qualifications — typically pharmacy, medicine, or life sciences degree plus pharmacovigilance experience. EU/EEA residence is mandatory. Language skills sufficient for EMA and national authority interaction are practical requirements.
No. QPPV is an EU regulatory requirement for EU-marketed products. US-only products have no QPPV requirement. Global products typically have both QPPV (EU) and a US pharmacovigilance lead with analogous responsibilities under FDA framework.
Related Terms
Related Use Cases
Related Regulatory Intelligence
Related Actions
Track every sequence operation, amendment, and supplement across the product lifecycle.
Monitor FDA, EMA, ICH, and Health Canada guidance changes across active programs.
Plan, validate, and execute active submissions in one workspace.
Sources & References
